Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
about
Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment ResponseAdvanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinomaThe Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging BiomarkersTherapy response with diffusion MRI: an updateNew paradigm for management of hepatocellular carcinoma by imaging.Diffusion MRI in early cancer therapeutic response assessment.Uveal Melanoma Metastatic to the Liver: The Role of Quantitative Volumetric Contrast-Enhanced MR Imaging in the Assessment of Early Tumor Response after Transarterial Chemoembolization.Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib.Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response MappingComparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoemboHepatocellular carcinoma: IVIM diffusion quantification for prediction of tumor necrosis compared to enhancement ratios.Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteriaInterreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinomaHypo-Vascular Liver Metastases Treated with Transarterial chemoembolization: Assessment of Early Response by Volumetric Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance ImagingPredictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE.Functional imaging techniques in hepatocellular carcinoma.Imaging tumor response following liver-directed intra-arterial therapy.Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI.New concepts in embolotherapy of HCC.Imaging review of hepatocellular carcinoma after thermal ablation: The good, the bad, and the ugly.Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study.The status of transarterial chemoembolization treatment in the era of precision oncology.Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma.
P2860
Q26740616-9017AE3A-80D0-44DF-B9FC-C04A121FD775Q26745449-127A95E1-4D11-4BC0-852C-8C19CCF82690Q26768460-217F97F9-6BA9-4C93-8B67-FE375284C2B0Q26851700-16E1E196-B94D-4692-A61B-44F28CE6E195Q30448048-3CC7BA47-0726-4075-AA16-7496DE5271B6Q31037179-21B45031-F0AF-45E2-BE24-6BBFAB8571AAQ34369283-AFF69CD6-B5E2-4FFC-87EB-55115D989C5FQ35073497-36E45099-7EF0-4110-9C3B-12917B52C265Q35163735-7939BAB9-FD16-4987-804B-78CF03580B91Q35234472-3298F3B6-FD42-452B-9799-A7CA5BC113E9Q36305786-06347198-DDFC-46F2-9E0F-8F7AA8096C9FQ36416250-2B67F08F-A747-4A35-BAA9-B12F796FAEC2Q36630342-5921E1F0-24F9-49D4-805B-7E4A0B96630AQ36740054-AEA45C8B-3071-41D3-808C-7837C0FCFD07Q37039550-415DBC17-D5E5-4660-8EF8-83F4129F5265Q37143017-888E1245-3465-4390-9C3D-CC1D388ADA20Q37221919-5C69463B-832A-488E-83A4-E80E4D7E929EQ37382576-88DB089A-6BB2-487D-8DF1-366677979BD9Q37995486-5909C379-CB15-4E6F-85D7-6E2996AD6522Q38117579-1CF3D092-7801-4E7F-A92D-28CCCADCAB1FQ38172834-17AA6B6D-16D7-4F2A-97DB-E5B936B7AE30Q38177763-4BF437C3-C254-4687-8F78-8B9C0C656DA5Q38265114-49AFE06C-8F04-4873-8F60-A7BDCF41C79CQ38904263-8E87E23B-B508-45A0-9F6E-A07FF1A49FF2Q38922919-33DD5415-0952-463D-AE8D-3C05F129CB09Q39380520-BF7A0F10-075D-4203-A0B7-3A9A2DC85827Q41534428-EBC42096-5992-4BE1-868F-95B34CA8E02EQ49491370-65108759-F47E-43F3-BEC3-158A49078078Q50218004-736498EC-8D29-4894-A6EE-23A4ED52D29DQ53000448-7C58EF6F-73FD-4528-9F7E-F2994BA9FC2AQ53163577-6D3D363B-EB52-480A-B5F2-1237DA8CB8E3Q54997346-6C2CD64C-4EF6-472A-8D87-F697273508DA
P2860
Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@ast
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@en
type
label
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@ast
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@en
prefLabel
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@ast
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@en
P2093
P356
P1433
P1476
Hepatocellular carcinoma: resp ...... rast-enhanced MR imaging data.
@en
P2093
Atilla P Kiraly
Ihab R Kamel
Mehmet Akif Gulsun
Prashant Jolepalem
P304
P356
10.1148/RADIOL.11102330
P407
P577
2011-07-19T00:00:00Z